Among the many factors influencing fibrin formation and structure (concentration, temperature, composition, pH,…), it has been suggested that the polydispersity of fibrinogen may play an important role. We propose here a detailed investigation of the influence of this parameter on fibrin multiscale structure.
Introduction
The formation of the fibrin clot is essential in the process of blood coagulation. Fibrin forms a protein scaffold that enables the organism to close off damaged blood vessels. In the first step of fibrin formation, the fibrinopeptides A and B from the protein fibrinogen are cleaved by thrombin, producing the so-called fibrin monomers which then polymerize into a fibrin network. Fibrinogen itself is a plasma 340-kDa centrosymetric protein. Its structure is constituted by three aligned domains. The central part of the molecule (E-region) is slightly smaller (c.a. 5nm of diameter) while the distal regions (D-regions) present a 6nm diameter to form a structure about 45nm in length.
While some aspects of the formation of the fibrin network from fibrin monomers are still under debate, it is known that various genetic and environmental factors influence not only the fibrin structure and function but that they can also be related with thrombotic disease (e.g. 1).
Indeed, many clinical studies have associated the fibrin properties with thrombosis (2, 3) .
Among the many factors influencing fibrin polymerization, structure and function (ionic strength, pH, concentrations, ' content … (4-9)), Huang et al. (10, 11) suggested that the size dispersity, i.e. the amount of aggregates or oligomers present in the fibrinogen preparation, may play an important role. Indeed, fibrins made from chromatography fractionated fibrinogen exhibited final turbidities between two and three times higher than the unfractionated samples (10) , and significant differences both in kinetics as well as in the apparent size of the polymerizing objects were observed in a later study (12) . However, a Small Angle X-Ray Scattering study of this fractionation process showed significant in-column degradation (13) and gel filtration could change the concentration in important proteins present in the fibrinogen preparations (called co-purified proteins), such as fibronectin, FXIII, … Likewise, fibrinogen isoforms (glycoforms, ' content, oxidized forms, N-/C-terminus cleaved forms, …) are likely to be prone to variability during the chromatography fractionation process and therefore to behave specifically vis-à-vis polymerization.
As the relative compositions of the mono-and poly-disperse fibrinogen preparations were not characterized nor the molar masses of the different fractions measured, the question of In the last decade or so, about 75% of the fundamental work on fibrin formation has been performed on fibrinogen from Enzyme Research Laboratories (see Supporting Information (SI) S1), hence with rather constant compositional and polydispersity profiles. While this is pertinent for comparison purposes, the effect of fibrinogen's polydispersity may have been entirely overlooked in the current fibrin-related literature, while it is a well-known factor in standard polymer science (e.g. 14) .
The above observations raise four important questions. First, does fibrinogen dispersity really influence the multiscale structure of fibrin, or were Huang et al. observations (11) a consequence of the purification procedure they used? Second, what are the scales affected by dispersity and how are those scales affected? Third, are those differences also observed at physiological fibrinogen concentrations (2-4 mg/ml) or limited to the very low concentrations used in previous studies? Finally, are the dispersity-induced structural effects important? In other words, are they smaller or larger than those induced by varying compositional aspects of the fibrinogen preparations?
In the following, we start by describing the numerous experimental methods used in this work. To characterize the two fibrinogens, we performed Refractive index and MALLS-coupled Size Exclusion Chromatography, Dynamic Light Scattering, Reverse phase chromatography coupled to mass spectrometry, and all necessary co-purified proteins quantification assays. The methods used to determine the structure of the fibrins at each scale are then described, starting with Small Angle X-Ray Scattering, Spectrophotometry, and finally Confocal Microscopy.
Then, we present the detailed characterization of the physical and physicochemical properties of the different fibrinogens, showing that the two fibrinogens used in this study present identical compositional profiles while differing strongly in their aggregate content. We then investigate the effect of this size dispersity on the nano-and micro-scale structure of the fibrin, showing that the two fibrins present vastly different structures, at all scales. We finally discuss the present findings in the light of recent results concerning the effect of compositional and isoform changes on fibrin structure and propose a mechanistic explanation of our results.
Materials and Methods

Materials
Human thrombin was purchased from Cryopep (Montpellier, France) as a 12 L solution containing 298,9 IU. The solution was diluted to 200 IU/ml in a 2-(N-morpholino)ethanesulfonic (MES) buffer (20mM MES, 50mM NaCl, pH 6.5) aliquoted and kept frozen at -80°C.
Two fibrinogens were used: Clottafact (Laboratoire Français du Fractionnement et des Biotechnologies, Les Ulis, France) and Fib1 (Enzyme Research Laboratories, Swansea, UK).
Fibrinogens were reconstituted using manufacturers' guidelines: Fib1 and Clottafact fibrinogens were reconstituted by adding respectively 25 mL and 100 mL of Sterile Water for Injection into the product vials. Then, the product vials were incubated at 37° C and gently swirled until the product was fully dissolved. Both fibrinogens were dialyzed together twice overnight against 
Sample preparation
Fibrinogens were thawed at 37°C for 5 minutes and equilibrated at room temperature for another 5 minutes before use, filtered with a 0.2 m ClearLine syringe filter. Concentrations were then determined by absorbance at 280 nm, and adjusted as desired. Thrombin was thawed at 37°C for 1 minute, diluted in HEPES buffer and immediately used. 
Size exclusion chromatography
The molecular distribution of the different fibrinogens was analyzed using a Superose 6 column (GE Healthcare, USA) on an Elite LaChrom system (Hitachi, Japan), coupled with a Dawn Heleos II -Multi-Angle static Light Scattering system (Wyatt Technology, Santa Barbara, USA) and a Optilab T-rex -Refractometer (Wyatt Technology). The same HEPES buffer as before was used. Fifty microliters of fibrinogen (5 mg/ml) were applied and the column was developed at a 0.5 ml/min flow rate. Elution (=280 nm), MALLS and Refractometer profiles were analyzed using the ASTRA software from Wyatt Technology.
Dynamic Light Scattering
Dynamic Light Scattering measurements were performed using a CGS-8FS/N069 apparatus from ALV Technology (Manila, Philippines) with a 35 mW, 632.8nm laser from JDSU (Milpitas, CA, USA). Fibrinogens (1 mg/ml) were loaded in 10 mm diameter cylindrical cells, immerged in a toluene bath at 25.0 ± 0.1 °C. Data were collected at 90° for 120 s. Hydrodynamic radii distributions were determined using Contin analysis.
Protein assays
Fibronectin level was assayed on a Siemens BNII nephelometer. Briefly, the sample is mixed with a polyclonal rabbit anti-Human fibronectin to generate immune complexes measured by nephelometry. The fibronectin concentration is deduced by interpolation with a standard curve using the Dade Behring N protein standard PY. 
Reverse phase chromatography coupled to mass spectrometry (MS)
Small angle X-ray Scattering
Small Angle X-ray Scattering (SAXS) experiments were performed at the ID02 line at the European Synchrotron Radiation Facility (ESRF, Grenoble, France). The samples (2 volumes of fibrinogen and 1 of thrombin) were mixed directly in a 12mm x 12mm x 3mm home-made cell with 20 µm mica windows, thermostated at 37± 0.3°C (16) . The sample-to-detector distance was set to 7 m and the acquisition time was set to 0.1 s. To avoid radiation-induced degradation of the protein, the cell was displaced by a motorized x-y stage between each measurement in a snake-like fashion, by 2 mm horizontally and 2 mm vertically at the end of a line, i.e. each time by a distance much larger than the beam size (0.5x0.5 mm). The results presented here are the average of the 15 last acquisition times corresponding to steady state scattering curves. The constancy of the signal over several centimeters of the cell shows that the polymerization was finished and that the initial mixing was good. A comparison between two replicate experiments is presented in SI S5, fig. SI.6.
Spectrophotometry
Fibrin gels were formed in 96-well Immulon 2HB plates (Fischer scientific, Illkirch , France) by mixing 2 volumes of fibrinogen (120 µl) and 1 of thrombin (60 µl). Optical density spectra (500 nm to 800 nm) were measured after 90 minutes at 37 ± 0.3 °C using a SpectroStar Omega (BMG Labtech Ortenberg, Germany). For the total volume used in the experiments, the path length was 4.38 mm as determined from calibration using a range of known absorbances.
Optical density data were analyzed using a corrected version of Yeromonahos's (7, 15, 16) model. See SI S4 for a discussion concerning the model choice and pertinence. Each data point represents the mean and standard deviation calculated from at least 12 individual experiments.
Confocal Microscopy
Microscopic images of fibrin networks were obtained using Alexa488 fluorescent fibrinogen (Invitrogen, Breda, Netherlands) mixed with the unlabelled fibrinogens at a 1:10 ratio. Each mixture was filtered with a 0.2 m ClearLine syringe filter and the concentrations were then determined by absorbance at 280 nm. Samples were polymerized using 0.1 IU/ml of thrombin and various fibrinogen concentrations (0.5, 1 and 3 mg/ml). Fibrinogen and thrombin were mixed in Eppendorf Tubes 3810X, then rapidly injected in Secure Seal Hybridization Chambers (Grace Biolabs, Bend, OR, USA) and polymerized during 60 minutes at 37° C. Confocal image stacks of the fibrin networks were acquired using a Zeiss LSM710 confocal microscope with a 63x/1.2 water immersion objective (Zeiss, Oberkochen, Germany). The 3D stacks were 67.5 µm in the x-y direction and 25 µm in the z direction with resolutions of 100nm and 250nm respectively. The confocal image stacks of the fibrin networks are homogeneous both in the imaging plane and also in depth (data not shown).
For the visualization and presentation of those stacks, we used a recently developed ImageJ plugin: Smooth Manifold Extraction (SME) (17) . This method, unlike z-maximum intensity projections, provides a robust 2D representation of 3D objects which preserves local spatial relationship, in particular branching (see SI S6.1 for details and examples). Finally, the pore size was determined using the bubble method (18, 19) . For details about the segmentation and pore size analysis, see SI S6.2.
3 Results.
Physico-chemical characterization.
Molecular size distribution
The SEC elution profiles of the two fibrinogens are presented in Fig. 1 . They both show a main peak at an elution volume of 11ml, as well as a small broad peak around 9.3 ml, albeit with different intensities (Fib1 > Clottafact). In addition, Fib1 presents a well-defined high A (weight-averaged) molar mass of 325 kDa is obtained for the 11 ml elution peak observed in both fibrinogens, which corresponds closely to the molar mass of fibrinogen monomers (e.g. 13) . The ratio of the weight-averaged mass to the number-averaged mass (Mw/Mn) for this peak is below 1.01, indicating good monodispersity. For the broad small peak at 9.5 ml also observed in both fibrinogens, a molar mass of about 1 MDa is obtained, with a significant polydispersity, corresponding probably to a distribution of oligomers. Finally, a mass of about 5 MDa can be assigned to the large peak observed at 7.5 ml in Fib1, corresponding most likely to fibrinogen aggregates. The elution profile and molar masses obtained for Fib1 are in excellent agreement with those of Brookes et al. (13, fig. 3 ) which were also obtained on Fib1 fibrinogen, but using a size exclusion chromatography column coupled to a small angle X-ray scattering cell.
Those results demonstrate the presence of both oligomers and large aggregates in Fib1 while the Clottafact preparation is close-to-monodisperse with a small amount of oligomers and no detectable aggregates. The relative mass of the aggregates present in Fib1 is found to be of about 4% of the total mass of fibrinogen.
Dispersity analysis by Dynamic Light Scattering
Dynamic Light Scattering (DLS) was used to confirm the above results by determining the average hydrodynamic radius of the different fibrinogens. Since the SEC-MALLS results showed a tri-disperse size distribution, we tried to use a triple exponential fit of the raw correlation spectra to obtain the hydrodynamic size distribution of the molecules. However, those fit were not robust as the result was strongly dependent on the initial values used for the fit. Therefore, we only present the average hydrodynamic radii and the polydispersity indexes obtained by a Contin analysis.
Clottafact fibrinogen has a hydrodynamic radius of 11nm, a hydrodynamic size corresponding well to that of fibrinogen monomers (11, 12, 20, 21) . The measured polydispersity index is of 25%, close to the value of 20% below which samples are considered truly monodisperse. Conversely, Fib1 fibrinogen has a hydrodynamic radius of 22nm, with a polydispersity index of 52%. This result confirms that Fib1 fibrinogen presents mixtures of higher molecular weight species.
RP-HPLC-Mass Spectrometry analysis
The two fibrinogens were further analyzed by RP-HPLC-Mass Spectrometry after Finally, SDS-PAGE of reduced fibrinogens showed similar '/ chains ratio with 14% for Clottafact and 10% for Fib1 (data not shown).
Co-purified proteins content
Co-purified proteins (FXIII and fibronectin) concentrations measured as described in materials and methods are shown in table 1 (see also SI2.1 and fig. SI.1) . The main finding is that Clottafact and Fib1 have almost identical composition in co-purified proteins. The only slight difference is the fibronectin content (0.05 vs 0.02 mg/mg) which is low compared to the normal plasmatic value (0.12 mg/mg), and much smaller than the range for which significant structural variations are observed in the literature (0.8 mg/ml) (21, 22 ) (see SI3, Table SI3 .1). The results of the physico-chemical analyses are summarized in table 1 and show that the composition of the two fibrinogens is almost identical except for the presence of large molecular weight aggregates.
Fibrin's ultrastructure
Since polydispersity could influence fibrin structure at the molecular, fiber and network scales, each scale was investigated with the appropriate tool (see figure 2 ).
Fibrin fibers internal structure.
We used Small Angle X-Ray Scattering to determine the molecular organization inside fibrin fibers. Figure 3A shows X-ray intensity spectra obtained on mature fibrin clots. The general shape of the scattering curves is identical to those available in the literature (7, 18 showing the excellent reproducibility of the protocols and methods. Spectra from each fibrin gel showed a main peak at a q-vector  0.3 nm -1 corresponding to the usual 22.5 nm periodicity of half-staggered fibrin monomers. However, significant differences are observed around this peak,
i.e. between 0.2 and 0.5 nm -1 .
To isolate those differences, we adapted Missori et al. (23) method to our data: the loglog scattering curves were first fitted with an order 3 polynomial. This polynomial was then subtracted to the scattering data, yielding the curves shown in figure 3B and 3C. The data were fitted to two Gaussian distributions (23) , one for the main 22.5nm peak and the other Gaussian for the broad peak (dashed lines). It is obvious both in figure 3B and in figure 3C that Clottafact fibrin exhibits a much higher amplitude and narrower main peak than Fib1 fibrin. Clottafact fibrin also shows a welldefined secondary broad peak that is not observed for Fib1 fibrin (Fig. 3C ).
Clottafact (Fig. 3B) sharp peak is at q 1 = 0.284 nm -1 with a full-width-at-half-maximum (FWHM) of 0.0026 nm -1 and the second broader peak is at q 2 = 0.327 nm -1 with an FWHM of 0.094 nm -1 . The sharp peak can be assigned to a Bragg diffraction from a repeat distance of that is either much less regular (less crystalline) and/or that these fibers are much shorter or much curvier than Clottafact's. The lateral structure of those fibers is too weak to be analyzed, suggesting also a much less regular internal lateral structure. Those results indicate that the molecular organization of fibrin fibers made from Clottafact is close to crystalline both longitudinally and laterally while the fibrin fibers made from Fib1 are much less organized.
To extend the scope of the investigation, we performed spectrophotometry measurements (7) for a wider range of experimental conditions and numerous replicates, experiments that would have been unacceptably time-consuming on a synchrotron. Figure 4A shows that fibers from
Clottafact clots have about twice as many protofibrils than those from Fib1. This result holds from 0.4 to 3 mg/ml, i.e. up to the normal physiological range. The spectrophotometry method also determines the average radius of the fibers from which the protein density within the fibers can be deduced from = /( 2 ) (e.g. 7) . Figure 4B shows that the protein density inside Clottafact fibrin fibers is significantly larger (30-50%) than the density of fibers from Fib1. The range of density values obtained here are in agreement with previous work (15, 26) . The validity of the spectrophotometric model was further verified by confronting the internal density of the fibers to confocal pore size measurements (see SI S7 and fig. S10 for details).
To summarize the nanostructural findings, SAXS indicates that Clottafact fibrin fibers are close to crystalline whereas the internal structure of fibers produced from Fib1 fibrinogens is considerably less organized, e.g. amorphous or fractal as was advocated previously (7, 27, 30) .
Spectrophotometry results point in the same direction showing that Clottafact fibers possess a significantly higher internal density than Fib1 fibers.
Fibrin microstructure: Confocal microscopy
Finally, to check whether the fibrinogen preparation differences could also impact the microstructure, we investigated the network organization of fibrin clots at the micron scale. The 3D microstructure of the different fibrins is visualized using the recently developed "Smooth Manifold Extraction" (17) . The main asset of this method is that, unlike maximum intensity projections, it does not create spurious intersections (see SI6.1 for a comparison between the two methods). Major differences in the fibers geometry are observed in fig.5 : Clottafact fibrin shows needle-like fibers that are straight over several µm, while Fib1 produces networks with much shorter and curved fibers. The observed straightness of Clottafact fibers is in perfect agreement with the very large persistence length obtained in the SAXS measurements while Fib1 fibers shortness or snake-like characteristic is also in agreement with the much lower persistence length obtained from the SAXS measurements. 
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Another major difference between those two networks is highlighted in the insets of figure 5 . Clottafact's fibrin shows a rather small number of branches per branching node, typically looking like the contact point between needle-like fibers while Fib1 shows many starlike patterns, with many asymmetrical branches per node expanding in thin fibrin threads.
Discussion
The first aim of this article is to investigate whether or not fibrinogen dispersity influences the ensuing fibrin ultrastructure and how important it is with respect to compositionally-induced changes. A possibility to obtain such products would have been to replicate the fractionation process proposed by Huang et al (11) , followed by a complete determination of the fractionated fibrinogen composition. Unfortunately, this fibrinogen fractionation method has been shown to produce important amounts of in-column degradation products (13) which contaminated the elution peaks of the undegraded material. In consequence, we chose to test existing commercial fibrinogens preparations for dispersity.
Among those we tested, only Clottafact showed a close-to-monodisperse profile. For the second, polydisperse fibrinogen, we chose Fib1 fibrinogen which is the de facto reference since it has been used in the large majority of works dealing with purified fibrin structure and rheology (see SI1).
Clottafact Fib1
Figure 5. Qualitative geometry of the fibrin networks. Smooth Manifolds were extracted as described in material and methods from confocal microscopy stacks. Clots were formed using 3 mg/ml and coagulated using 0.1 IU/ml of thrombin. Frames are 67.5 µm wide. The insets are x2 enlargements of a portion of the original SME image (12x12 µm).
In the first part of this work we determined the Fib1 and Clottafact compositions by measuring their FXIII, fibronectin, and  intact-chains content, ' ratio as well as their Nglycosylation and post-translational modifications (see table 1 ). To evaluate if the variations in composition observed between Fib1 and Clottafact may have a significant impact on fibrin structure, we compiled the compositional effects on fibrin structure observed in the literature.
This compilation (table S3 .1 in SI3) shows that the measured Clottafact- branching looks like an aggregate and seems to act as a nucleus from which several fibres grow in a rather random fashion. To confirm that aggregates may act as nucleating centres, the average distance d between them (which is also the pore size) can be estimated and compared with the measured pore sizes. Aggregates are the centre of spheres of radius d/2: Because most Fib1 fibers appear to nucleate from those aggregates, the larger the aggregates content is, the more branches and hence the more fibres. Since the total fibrinogen mass is conserved, it further derives that the larger the aggregates content is, the smaller the Fig 6B shows that the internal density of the fibers is also significantly modified by the presence of aggregates, but in a less dramatic fashion than the number of protofibrils. As deduced from the confocal images above, a plausible hypothesis is that a large part of the Fib1 fibers actually grow from activated fibrinogen present in the aggregates, hindering the lateral growth through several phenomena. First, there will be steric hindrance because of the local presence of the aggregate and of the several neighboring fibers as shown in fig 6C. Second, to link between aggregates, the fibers can stick upon each other or the fiber can bend. In the latter case, such a bending will discourage lateral growth because the 22.5 nm periodicity will be partly lost. Finally, recent results suggest that it is the twisted conformation of both fibrinogen monomers and protofibrils that promotes the assembly of protofibrils into fibres, in agreement with earlier observations by Weisel's group (29) . Therefore, aggregates could disrupt the initial fibres natural helical geometry (12) 
Conclusions
We have first shown that Clottafact's fibrinogen is composed almost exclusively of fibrinogen monomers whereas Fib1 possess a significant amount of large aggregates.
Conversely, the detailed physico-chemical analyses of Clottafact and Fib1 show that their compositions are sufficiently similar not to influence the structure of the ensuing fibrins. Small angle X-ray scattering demonstrates that the internal structure of Clottafact's fibrin fibers is close to crystalline both laterally and longitudinally with a longitudinal persistence length of several microns. Conversely, SAXS shows that Fib1 fibers are much more disorganized with no perceptible lateral organization and a longitudinal persistence length of a few hundreds of nanometers. Those nano-structural observations are confirmed at the microscale by direct confocal imaging. Clottafact fibrin displays long, needle-like fibers while Fib1 fibrin shows short and curved fibers in agreement with the SAXS persistence length measurements. Those results are further strengthened by spectrophotometry measurements which confirm the much larger density of the Clottafact fibers with respect to Fib1 ones. Those structural differences hold at all studied concentrations including physiological ones and demonstrate that the size dispersity of fibrinogen in purified systems is one of the main parameters determining fibrin fibers ultrastructure, parameter that has been mostly overlooked. Indeed, the effect of modifying the dispersity is surprisingly large, larger than changing any other aspect of the fibrinogen preparation.
Those results open outstanding questions regarding the precise mechanisms by which the presence of aggregates can influence to such an extent the polymerization of fibrin and, therefore, concerning fibrin polymerization itself. Furthermore, given the extensive structural modifications accompanying the presence of aggregates, the mechanical properties of fibrin clots formed from monodisperse fibrinogens may be very significantly different from the polydisperse ones and could be of paramount interest in tissue engineering on fibrin scaffolds as well as for the design of fibrin glues.
Finally, the actual amount of aggregates in circulating fibrinogen is not known as only a few studies investigated the multiscale structure of fibrin formed in plasma. Such investigations could be of outstanding interest in hemostasis, in particular in relation to thrombosis related diseases. 
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